It's only early December, but already there's been some nasty norovirus outbreaks in the U.S. One was bad enough to close an entire school. Another hit 400 people at the U.S. Air Force Academy. In response, some bits of wisdom (and humor) about this dreaded stomach bug.
Vaxart, a biopharmaceutical company, is working on a vaccine for the dreaded norovirus. The company just released its Phase Ib results. Did it work? Our lips are sealed. But here are some thoughts on its chances for success.